Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes-Reference-Cited by-同舟云学术

Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes

Published:2021-03-30 Issue:1 Volume:30 Page:12-19
ISSN:2508-6235
Container-title:Journal of Obesity & Metabolic Syndrome
language:en
Short-container-title:Journal of Obesity & Metabolic Syndrome

Author:

Seo Young-Gyun¹^ORCID

Affiliation:

1. Department of Family Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea

Publisher

Korean Society for the Study of Obesity

Subject

Endocrinology, Diabetes and Metabolism

Link

http://pdf.medrang.co.kr/KSSO2/2021/030/KSSO2030-01-12.pdf

Reference53 articles.

1. Food and Drug Administration. Prescribing information for Saxenda, 2018 [Internet]. Maryland:Food and Drug Administration; 2018 [cited 2020 May 29]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206321s007lbl.pdf..

2. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events

3. The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis

4. Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial

5. Impact of Liraglutide on Amylase, Lipase, and Acute Pancreatitis in Participants With Overweight/Obesity and Normoglycemia, Prediabetes, or Type 2 Diabetes: Secondary Analyses of Pooled Data From the SCALE Clinical Development Program

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent and Upcoming Therapies for Management of Type 2 Diabetes: A Review;Preventive Medicine: Research & Reviews;2024-08-13

2. Liraglutide innovations: a comprehensive review of patents (2014–2024);Pharmaceutical Patent Analyst;2024-07-16

3. The role of glucagon-like peptide-1/GLP-1R and autophagy in diabetic cardiovascular disease;Pharmacological Reports;2024-06-19

4. Acute Kidney and Liver Injury Associated With Low-Dose Liraglutide in an Obese Adolescent Patient;Pediatrics;2024-06-12

5. Liraglutide effectiveness in preoperative weight-loss for patients with severe obesity undergoing bariatric-metabolic surgery;Updates in Surgery;2024-04-04